Tablets - 25 mg
Solution for injection - (0.1%) 1 mg/1 ml
Tablets - 5 mg
Solution for injection - (10%) 1 g/10 ml
Tablets - 500 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Tablets - 850 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Film-coated tablets - 1000 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Solution for injection – (100 mg + 50 mg + 0.5 mg) / 2 ml
Tablets - 200 mg
Nicotinamide and nicotinic acid (vitamin PP), are water-soluble vitamin B substances. They are converted in organism to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). These two products are important coenzymes which are involved in the respiratory chain.
Nicotinic acid deficiency develops when the dietary intake is inadequate. Deficiency leads to the development of a syndrome known as pellagra, characterized by skin lesions, especially on areas exposed to sunlight, with hyperpigmentation and hyperkeratinisation. Other symptoms include diarrhoea, abdominal pain, glossitis, stomatitis, loss of appetite, headache, lethargy, and mental and neurological disturbances.
It is indicated in:
Solution for injection - (4%) 40 mg/1 ml
Film – coated tablets – 500.000 IU
Film – coated tablets – 500.000 IU
Tablets - 5 mg
Solution for injection - (5%) 100 mg/2 ml
Solution for injection - 300 000 IU/ml
Solution for injection - 840 mg/10 ml
Bikarbonat natriumi 840 mg / 10 ml is a preparation which is injected into the vein.
It is used to restore normal pH to the body after a cardiac arrest. During a cardiac arrest (stopping of the heart), a considerable amount of acid in the body can be accumulated (metabolic acidosis). As sodium bicarbonate is alkaline, it is used to neutralize this acidity.
Solution for injection - (40%) 4 g/10 ml
Solution for infusion - 5% (50 g/1000 ml)
Solution for infusion - 5% (50 g/1000 ml)
Glucose is a monosaccharide, which by mouth, but mainly parenterally, is used as a source of energy; it takes part in the metabolism of lipids and prevents acidosis by increasing the hepatic nitrogen content. The latter function has been used to prevent and to treat intoxications from medicines which are hepatotoxic. In absence of a sufficient quantity of glucose, lipids are highly oxidized and the intermediate products, such as: hydroxybutyric acid and acetoacetic acid are accumulated in blood becoming a potential cause for ketoacidosis.
It is indicated for fluid replacement and to provide the necessary energy, as a parenteral nutrition of severely-ill patients, in hypoglycemia; in intoxications with different substances (barbiturates, morphine, salicylates, mercuric compounds).
Solution for infusion - 5% (50 g/1000 ml)
Glucose is a monosaccharide, which by mouth, but mainly parenterally, is used as a source of energy; it takes part in the metabolism of lipids and prevents acidosis by increasing the hepatic nitrogen content. The latter function has been used to prevent and to treat intoxications from medicines which are hepatotoxic. In absence of a sufficient quantity of glucose, lipids are highly oxidized and the intermediate products, such as: hydroxybutyric acid and acetoacetic acid are accumulated in blood becoming a potential cause for ketoacidosis.
It is indicated for fluid replacement and to provide the necessary energy, as a parenteral nutrition of severely-ill patients, in hypoglycaemia; in intoxications with different substances (barbiturates, morphine, salicylates, mercuric compounds).
